We are live on ! Find out more
EDIT icon

Editas Medicine
EDIT

237 hedge funds and large institutions have $517M invested in Editas Medicine in 2023 Q2 according to their latest regulatory filings, with 43 funds opening new positions, 75 increasing their positions, 48 reducing their positions, and 39 closing their positions.

New
Increased
Maintained
Reduced
Closed

73% more call options, than puts

Call options by funds: $8.36M | Put options by funds: $4.83M

56% more repeat investments, than reductions

Existing positions increased: 75 | Existing positions reduced: 48

35% more capital invested

Capital invested by funds: $384M → $517M (+$133M)

10% more first-time investments, than exits

New positions opened: 43 | Existing positions closed: 39

1% more funds holding

Funds holding: 234 → 237 (+3)

1.04% more ownership

Funds ownership: 76% → 77.04% (+1%)

Holders
237
Holders Change
+3
Holders Change %
+1.28%
% of All Funds
3.72%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
43
Increased
75
Reduced
48
Closed
39
Calls
$8.36M
Puts
$4.83M
Net Calls
+$3.53M
Net Calls Change
+$2.39M

Top Buyers

1
DTC
Deep Track Capital
Connecticut
+$30.1M
2
APM
Avidity Partners Management
Texas
+$26.1M
3
Marshall Wace
Marshall Wace
United Kingdom
+$24.7M
4
GCM
Ghisallo Capital Management
Massachusetts
+$8.49M
5
Vanguard Group
Vanguard Group
Pennsylvania
+$8.39M

Top Sellers

1
State Street
State Street
Massachusetts
-$13.3M
2
Citadel Advisors
Citadel Advisors
Florida
-$11.2M
3
PHS
PFM Health Sciences
California
-$5.22M
4
Bank of America
Bank of America
North Carolina
-$4.48M
5
Citigroup
Citigroup
New York
-$3.88M
Name Holding Trade Value Shares
Change 		Change in
Stake
Bank of America
26
Bank of America
North Carolina
$3.52M -$4.48M -513,762 -55%
Voloridge Investment Management
27
Voloridge Investment Management
Florida
$3.35M +$1.68M +192,692 +90%
ECM
28
ExodusPoint Capital Management
New York
$3.28M +$3.25M +373,454 +1,516%
TLP
29
Tri Locum Partners
New York
$3.05M +$3.23M +370,877 New
Mirae Asset Global Investments
30
Mirae Asset Global Investments
South Korea
$2.87M +$274K +31,420 +10%
BNP Paribas Financial Markets
31
BNP Paribas Financial Markets
France
$2.79M -$891K -102,269 -23%
Citadel Advisors
32
Citadel Advisors
Florida
$2.76M -$11.2M -1,287,715 -79%
Barclays
33
Barclays
United Kingdom
$2.46M +$211K +24,164 +9%
Bank of New York Mellon
34
Bank of New York Mellon
New York
$2.26M +$100K +11,491 +4%
SOMRS
35
State of Michigan Retirement System
Michigan
$2.25M – – –
Jane Street
36
Jane Street
New York
$2.22M +$1.35M +154,871 +136%
Susquehanna International Group
37
Susquehanna International Group
Pennsylvania
$2.21M +$122K +14,029 +6%
Norges Bank
38
Norges Bank
Norway
$2.2M – – –
RJA
39
Raymond James & Associates
Florida
$2.13M +$1.35M +154,566 +148%
Qube Research & Technologies (QRT)
40
Qube Research & Technologies (QRT)
United Kingdom
$2.07M +$734K +84,209 +50%
Wells Fargo
41
Wells Fargo
California
$1.78M +$10.3K +1,182 +0.5%
TCM
42
Tang Capital Management
California
$1.65M +$1.74M +200,000 New
Citigroup
43
Citigroup
New York
$1.54M -$3.88M -445,421 -70%
UBS Group
44
UBS Group
Switzerland
$1.53M -$2.72M -312,223 -63%
Swiss National Bank
45
Swiss National Bank
Switzerland
$1.46M +$252K +28,900 +19%
Capital Fund Management (CFM)
46
Capital Fund Management (CFM)
France
$1.31M -$704K -80,819 -34%
Renaissance Technologies
47
Renaissance Technologies
New York
$1.29M +$1.36M +156,300 New
Stifel Financial
48
Stifel Financial
Missouri
$1.22M +$51.5K +5,909 +4%
State of Wisconsin Investment Board
49
State of Wisconsin Investment Board
Wisconsin
$1.12M -$218K -24,973 -15%
SFI
50
Susquehanna Fundamental Investments
Pennsylvania
$982K -$664K -76,215 -39%
1
2
3 4 5

EDIT Hedge Fund Activity: Q2 2023 in Review

237 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in Editas Medicine (EDIT) for Q2 2023, worth a combined $517M — up 35% from $384M a quarter earlier.

Buyers outnumbered sellers: 43 funds opened new EDIT positions and 39 closed out — a net gain of 4 holders — while 75 added to existing stakes and 48 trimmed.

The largest buyer was Deep Track Capital, opening a new position worth an estimated $30.1M. The largest seller was State Street, cutting an estimated $13.3M.

  • 237 institutional investors held Editas Medicine (EDIT) as of Q2 2023, up from 234 in Q1 2023.
  • Funds reported $517M of Editas Medicine stock for Q2 2023, up 35% quarter-over-quarter.
  • 43 funds opened new Editas Medicine positions in Q2 2023 and 39 closed out, a net change of +4 holders.
  • The largest Editas Medicine buyer in Q2 2023 was Deep Track Capital, an estimated $30.1M added.
  • The largest Editas Medicine seller in Q2 2023 was State Street, an estimated $13.3M sold.

Based on aggregated 13F filings for Q2 2023.